Icon

COMPLERA - (200MG; EQ 25MG BASE; 300MG, Tablet Oral)

EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR DISOPROXIL FUMARATE Gilead
200MG; EQ 25MG BASE; 300MG, Tablet Oral
Less Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
Less Than 5
None None
Indicated as a complete regimen for the treatment of HIV-1 infection
Yes
***** ** *** ***** ** **** **** ** **** ******* '*** (*** *, ****), '*** (**** *, ****), '*** (*** **, ****), '*** (*** **, ****) *** *** ************ *********. ** ****** **** **** ***** ******* ** *** ****. ******* *** ****** ******* ***** * ******* ** *** ***** ******* ******* (*** *, ****); ******* (*** **, ****); ******* (*** *, ****); ******* (*** **, ****); ******* (***-**); ******* (***-**); *******; (***-**) *** ******* (***-**) ** *** *** *******. *** **** ** ***** ***** *** ****** *** ******* *** *********** ** *** *********.
COMPLERA Patent 1 Patent 2 Patent 3 Patent 4 Patent 5 Patent 6 Patent 7 Patent 8 Patent 9 Patent 10 Patent 11
***** ******* ******* ******* *** ********* *** ********* ******* *** ********* (***** ******) *** ********* (***** ******) *** ********* (***** ******) ******* *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
***** *** \ ********* *** **** ******* ********* ******** ** ** ****
  1. *** **, **** : ****** ******** ******* *** ****** ***** *** **** ** *** ******** **** ******* '*** (*** *, ****), '*** (**** *, ****), '*** (*** **, ****), '*** (*** **, ****).
  2. *** **, **** : ****** *** ****** ***** * **** ******* ***** ** ******** ***** ** ******** *** ******** ***** ** **** ******** ********.
  3. *** *, **** : ***** ***** **** ** **** '***, '*** *** '*** ** ******* *** *** **** ** ****** *** ****** ** ** ** **** ******** *** ********.
  4. *** *, **** : ******* *** ****** ******* ********** **** ***** ** *********** *****.
  5. *** *, **** : ******* *** ****** ******* ***** * ******* ** *** ***** ******* *******; *******; *******; *******; *******; *******; *******; *** ******* ** *** *** *******.
  6. *** *, **** : ******* *** ****** ******* ***** * ******* ** *** ***** ******* *******; *******; *******; *******; *******; *******; *******; *** ******* ** *** *** *******.

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.